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FUNCTIONAL STUDY OF ROBO2 MISSENSE MUTATION IDENTIFIED IN 
PATIENTS WITH CONGENITAL ANOMALIES OF THE KIDNEY AND 
URINARY TRACT (CAKUT)  
 




Background: Congenital anomalies of the kidney and urinary tract (CAKUT) is in the 
family of structural renal tract birth defects. CAKUT is the major cause of chronic kidney 
disease and renal failure in children and adults <40 years of age. ROBO2 is a receptor for 
the SLIT2 ligand. ROBO2/SLIT2 signaling has been shown to play important roles in 
neuronal migration and in early renal tract development. Our laboratory has recently 
identified ROBO2 as a novel CAKUT-causing gene. So far, total 26 ROBO2 mutations 
have been identified in patients with CAKUT. However, most of these mutations are 
missense amino acid substitutions and their functional significances are unclear, although 
they are predicted to be disease-causing by several bioinformatics prediction software.  
Objective: To clarify uncertainties and confusions in the CAKUT field regarding the 
causality for ROBO2 missense mutations, we performed functional analysis of a ROBO2 
missense mutation p.G114W (c.340G>T) that was identified in a CAKUT family. This 
p.G114W ROBO2 mutation is located in the first Ig domain of the ROBO2 extracellular 
region. The ROBO2 first Ig domain is the binding site for ligand SLIT2 that is required 
for ROBO2-SLIT2 signaling chemorepulsive activity in neuronal migration. We 
 
 vii 
hypothesize that this p.G114W ROBO2 mutation would disrupt the SLIT2-ROBO2 
binding and compromise its chemorepulsive activity in a sensitive functional neuronal 
migration assay.  
Methods: Site directed mutagenesis was used to introduce c.340G>T point mutation into 
a ROBO2 cDNA fusion construct that contains the first Ig domain. Point mutation was 
verified using Sanger sequencing. Mutant ROBO2 cDNA and wildtype control constructs 
were purified using Qiagen Midiprep kit and transfected in HEK cells via calcium 
phosphate co-precipitation. The conditioned medium (CM) containing ROBO2 fusion 
proteins were analyzed by Western Blot. Neuronal migration assays were performed 
using postnatal anterior subventricular zone (SVZa) tissue explants that were isolated 
from postnatal day 1 to 5 (P1-5) Sprague-Dawley rat brain.  
Results: By Sanger sequencing, we verified the c.340G>T point mutation in the ROBO2 
cDNA fusion construct. By GFP fluorescence and Western blot analysis, we found 
abundant expressions of ROBO2 fusion protein in the conditioned medium of transfected 
HEK cells. In SVZa neuronal migration assays, we found that, when compared to the 
wild type fusion protein, the mutant ROBO2 fusion protein with the p.G114W amino 
acid substitution lost its function to block SLIT2-medicated inhibition of neuronal 
migration at both 50% conditioned medium and 100% conditioned medium 
concentrations.   
Conclusion: Our results show that ROBO2 p.G114W is a loss-of-function mutation 
disrupting normal SLIT2-ROBO2 chemorepulsive activity on SVZa neuronal migration, 
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suggesting that the presence of this missense mutation compromises SLIT2-ROBO2 
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
 
1.1 Congenital Renal Anomalies Contribute to Pediatric Hospitalizations, Cost of 
Care, and Morbidity Rates. 
 
The prevalence of congenital anomalies is a large contributor to the 
hospitalization, morbidity, mortality, and cost of care for pediatric patients. A 1997 
population study in the states of California and South Carolina showed that 9-12% of all 
pediatric hospitalizations were due to genetic and congenital anomalies, with some 
variation based on race, ethnicity, and age (Yoon et al., 1997). The average age for these 
pediatric patients with congenital anomalies was about three years younger with the 
average hospital stay time being three days longer than for pediatric patients without 
congenital anomalies. These hospitalizations accumulated 184% higher charges and had a 
4.5 times greater in-hospital mortality rate than children who were hospitalized for other 
reasons. The highest hospitalization, morbidity, and mortality rates across all ethnicities 
were children <1 year of age, with a fixed decline in those rates with increasing age. 
Additionally, hospitalizations for genetic and congenital defects were much costlier than 
hospitalizations for any other disease proportionately (Yoon et al., 1997).  
Congenital anomalies of the kidney and urinary tract (CAKUT) is a subset of 
congenital anomalies in the renal tract, including kidney anomalies such as 
hypodysplastic kidney, and urinary tract defects such as ureteropelvic junction 
obstruction (UPJO) and vesicoureteral reflux (VUR). CAKUT accounts for about 60% of 
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underlying diagnosis in chronic kidney disease among the 0 to 12-year old age group. A 
recent study in New England Journal of Medicine also showed that adults diagnosed with 
End-Stage Renal Disease (ESRD) were often associated with childhood congenital renal 
anomalies even though they did not exhibit any form of renal dysfunction during 
adolescence (Calderon-Margalit et al., 2018). With such a large percentage of pediatric 
hospitalizations being due to congenital anomalies and CAKUT, in addition to childhood 
renal dysfunction being a large indicator of adult renal failure, it is important to study the 
genetic causes and disease mechanisms of many congenital anomalies of the kidney and 
urinary tract. 
 
1.2 Prevalence of Congenital Anomalies of the Kidney and Urinary Tract 
 
Currently, close to 8 million children and three percent of all live births in the 
United States are born with a serious birth defect of genetic origin (Peters & Rushton, 
2010; Rasouly & Lu, 2013; Williams, Fletcher, Alexander, & Craig, 2008). Among those 
affected, congenital anomalies of the kidney and urinary tract (CAKUT) involves close to 
0.5% of all pregnancies (Pope, Brock, Adams, Stephens, & Ichikawa, 1999; Williams et 
al., 2008). Major forms of CAKUT include ureteropelvic junction obstruction (UPJO), 
multicystic dysplastic kidneys (MCDK), hypoplastic kidneys, bladder outlet obstruction, 
non-obstructed, non-refluxing primary megaureter, and vesicoureteral reflux (Pope et al., 
1999). CAKUT is currently a leading cause of urinary tract infection (UTI), chronic 
kidney disease (CKD), and pediatric renal failure. Additionally, it may also display itself 
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as primary cause of renal failure in adults as more children with urinary tract birth defects 
survive to adulthood leading to increasing needs of dialysis and kidney transplantations in 
CAKUT patients.  
 
1.3 ROBO2/SLIT2 Signaling and CAKUT 
 
The SLIT2-ROBO2 signaling is a highly conserved signaling pathway that plays 
a large role in the regulation and development of several organs (Blockus & Chédotal, 
2016). In this pathway, the binding of the SLIT2 ligand to the ROBO2 receptor leads to 
an intracellular response. This intracellular response may have multiple outcomes such as 
cell migration, axon pathfinding, axon branching, regulation of cell fate, and proliferation 
(Brose et al., 1999; Dallol et al., 2002; Dickinson & Duncan, 2010; Dickinson, Myers, & 
Duncan, 2008; Dickson & Gilestro, 2006; Domyan et al., 2013; Gibson et al., 2014; 
Prasad, Qamri, Wu, & Ganju, 2007; Rhee, Buchan, Zukerberg, Lilien, & Balsamo, 2007; 
Wu et al., 2001; Athena R. Ypsilanti, Zagar, & Chédotal, 2010). The classical view of the 
SLIT2-ROBO2 signaling pathway in nerve system is summarized in Figure 1 (Pisarek-
Horowitz, 2015).  
In addition to its function in axonal pathfinding and neuronal migration, 
ROBO2/SLIT2 signaling plays an important role in early kidney and urinary tract 
development to control the ureteric bud outgrowth (Grieshammer et al., 2004). In 
humans, mutations of  ROBO2 and SLIT2 have also been identified in patients exhibiting 
the CAKUT phenotype (Hwang et al., 2015; Lu et al., 2007). Since its discovery as a 
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CAKUT-causing gene, one truncated and 25 missense mutations have been identified in 
human ROBO2 gene (Hwang et al., 2015). However, the functions and disease 
mechanisms of these 25 ROBO2 missense mutations have not been studied, which can 





Roundabout receptors (ROBO) were first discovered in Drosophila to regulate the 
midline crossing of commissural axons (Kidd et al., 1998). It was then named from its 
“roundabout” look from the crossing and recrossing of the midline by the axons in flies 
with ROBO mutations (Brose et al., 1999). Invertebrates have three ROBO genes 
(ROBO1-3) while vertebrates contain four (ROBO1-4) (Kidd et al., 1998). 
Since the extracellular domains of ROBO receptors contain a varied number of 
immunoglobulin (Ig) motifs, ROBO receptors are classified into the immunoglobulin 
family. The vertebrate ROBO1 and ROBO2 proteins share the highest degree of amino 
acid conservation. They each contain five immunoglobulin (Ig) domains followed by 
three fibronectin type III (FNIII) motifs while their intracellular domains contain four 
highly conserved short sequences named cytoplasmic conserved (CC) motifs (Figure 1) 
(Athéna R. Ypsilanti & Chedotal, 2014). ROBO3 lacks the first cytoplasmic conserved 
motif. ROBO4 is the most structurally divergent as it is missing two extracellular Ig 
motifs, two fibronectin type III domains, and only contains two of the cytoplasmic 
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conserved motifs (Kidd et al., 1998, Huminiecki et al., 2002). Mutational studies and 
partial crystal structure show that the SLIT2 ligand binds to the ROBO receptor in the 
first  Ig domain (Morlot et al., 2007a, Morlot et al., 2007b;) and is required for the 





Similar to ROBO receptors, SLIT proteins were discovered first as proteins that 
played a major role in midline crossing defects of neurons (Brose et. al., Seeger, Tear, 
Ferres-Marco, & Goodman, 1993) They’re a family of secreted extracellular molecules 
that bind to the first Ig domain of ROBO to activate downstream molecules for signaling 
transduction (Ypsilanti and Chedotal, 2014, Kidd et. al., 1998). In the same manner as 
ROBO, SLIT proteins are highly conserved across species (Brose et. al. 1999). Three 
distinct SLIT genes (SLIT1-3) have been identified in the mammalian genome, which 
contains several different motifs. These include four leucine rich repeats (LRR), seven to 
nine epidermal growth factor-like (EGF) motifs, followed by an ALPS domain 
(containing Agrin, Laminin, Perlecan, and SLIT homology sequences, also known as 
laminin-G domain), and a C-terminal cysteine knot (Brose et. al., Blockus & Chédotal, 
2016). Slit ligand proteins can be, and are often, modified post-translationally, being 
proteolytically cleaved by unknown proteases to form two fragments, a large 140 
kilodalton (kDa) SLIT-N and a smaller 60 kDa SLIT-C. These two fragments differ in 
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their biological activity (Brose et al., 1999; Wang et al., 1999). Both SLIT-N and SLIT-C 
fragments are active in the SLIT/ROBO signal activation pathway (Blockus & Chédotal, 
2016; Chen, Wen, Dupuis, Wu, & Rao, 2001). The smaller SLIT-C fragment was 
recently reported to play a role in activating Plexin3a, a guidance receptor for 
Semaphorin 3A, another secreted guidance cue protein (Chédotal, 2007; Delloye-
Bourgeois et al., 2015).  
 
1.3.3 SLIT2-ROBO2 Signaling 
 
 Currently, SLIT 1, 2, and 3 ligands function similarly in their activation of the 
ROBO1 and ROBO2 signaling pathways (Brose et al., 1999). As stated before, the 
ROBO family has a high degree of structural homology and therefore, ROBO1 and 
ROBO2 receptors have the same signaling components and bind SLIT2 ligands. 
 The binding of the LRR domain of SLIT2 to the first Ig domain of ROBO2 is 
what initiates the SLIT2/ROBO2 signaling process (Howitt, Clout, & Hohenester, 2004;  
Morlot et al., 2007b). This SLIT2/ROBO2 complex is best defined as a hand and glove-
like three-dimensional fit. SLIT2 binding to ROBO2 causes a change in the stereological 
conformation of ROBO2 that affects the intracellular portion and activating downstream 
effectors (Morlot et al., 2007b). The most well studied of these downstream effectors 
include, but are not limited to, Slit-Robo GTPase activating proteins (srGAPs), 
Dreadlocks (DOCK), Enabled (ENA), and Abelson (ABL) kinases (Bashaw, Kidd, 
Murray, Pawson, & Goodman, 2000; Fan, Labrador, Hing, & Bashaw, 2003; Wong et al., 
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2001) which continue to interact with other downstream effectors to regulate the 




























Figure 1: ROBO2 protein structure and its binding site for ligand SLIT2 in the 
nervous system. The SLIT2 ligand binds to the transmembrane protein ROBO2 at its 
first Ig domain (arrow) in order to elicit a downstream signal transduction leading to 
chemorepulsive neuronal migration or axon pathfinding. The extracellular region of 
ROBO2 contains five Ig domains (green) in addition to three FNIII motifs (blue). The 















1.3.4 ROBO and SLIT in the Kidney and Urinary Tract  
 
The expressions of SLIT1, SLIT2, ROBO1, and ROBO2 have been identified to 
play a significant role in the developing kidney (Piper et. al., 2000). Knockout mouse 
models of either the SLIT2 ligand or the ROBO2 receptor has been shown to cause 
supernumerary ureteric budding from the nephric duct leading to inappropriate kidney 
and ureter development and CAKUT phenotype (Grieshammer et al., 2004). Robo2 and 
Slit2 homozygous knockout mice have been shown to be born with multiple ureters, blind 
ureters, duplex kidneys, shorter ureters and hydronephrosis phenotype, which cause renal 
failure and perinatal death (Grieshammer et al., 2004).  
As mentioned previously, many ROBO2 mutations have been identified in 
patients displaying the CAKUT phenotype (Bertoli-Avella et al., 2008; Hwang et al., 
2014; Lu et al., 2007). However, most of these mutations are missense amino acid 
substitutions and their functional significances are unclear. A major objective of this 
thesis research project is to obtain functional evidence that Robo2 is causally linked 
to the observed CAKUT phenotypes in patients. Two paths have been considered 
that can lead to data sufficient enough to establish this level of scientific proof. The 
first is to use a mouse model to recapitulate human CAKUT phenotype due to the 
similarities between human and mouse orthologous genes and the anatomical 
structure of mouse and human kidney and urinary tract. These similarities allow for 
the use of knock-in/knock-out genetic engineering technologies to characterize the 
effects of CAKUT gene mutations in vivo in mouse models as reported previously 
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(Tripathi, Wang, Casey, & Chen, 2012; Yan et al., 2014). Another strategy is to 
determine if certain genetic mutations cause functional changes in vitro in the 
binding capacity of proteins in the signaling pathway that are known to play an 
important role in renal development, such as ROBO2 and SLIT2. Due to the time 
constraint of this thesis project, this study will be using the second strategy in vitro 
functional studies to determine the causation for the CAKUT gene ROBO2.  
 
1.3.5 ROBO2 p.G114W Mutation 
 
As mentioned before, 25 missense mutations have been identified in ROBO2 as 
potential causes of CAKUT via deoxyribonucleic acid (DNA) sequencing and 
bioinformatics prediction software. However, no functional studies have been performed 
to determine the pathogenesis of these ROBO2 missense mutations (Dobson et al., 2013). 
This study will attempt to elucidate the functional effect of one of these missense 
mutations of ROBO2, p.G114W, which was identified in a CAKUT family (Hwang et al., 
2014). This p.G114W mutation causes the amino acid change of glycine (G) to 
tryptophan (W) at the 114th position of ROBO2 protein (reference protein sequence: 
NP_001122401.1). The p.G114W mutation occurs when there is a nucleotide change of 
guanine to thymine at complementary deoxyribonucleic acid (cDNA) position 340 
(c.340G>T) in ROBO2 gene (reference cDNA sequence: NM_001128929.2). Besides 
Homo sapiens (human), this glycine is highly conserved in many other species including 
Mus musculis (mice), Gallus gallus (chicken), Xenopus tropicalis (frog), and Danio rerio 
(zebrafish), and the presence of c.340G>T in ROBO2 gene in the Exome Variant Server 
 
11 
(EVS) database is nonexistent (Table 1). It is also predicted by MutationTaster software 
(http://www.mutationtaster.org/) and SIFT (http://sift.bii.a-star.edu.sg) to be disease 
causing in addition to having a polyphen-2 score of 1 
(http://genetics.bwh.harvard.edu/pph2/) (Table 1). This score indicates that this mutation 
has an extremely high chance of being damaging and disease-causing (Hwang et al., 
2014). These data makes the p.G114W mutation a strong candidate for ROBO2 to be 



















Table 1. ROBO2 p.G114W (c.340G>T) missense mutation. 
 
Nucleotide change numbering refers to the cDNA position of ROBO2 transcript 
NM_001128929.2 
Amino-acid change numbering refers to the position of ROBO2 protein NP_001122401.1 
Species: Mm: Mus musculus (mouse); Gg: Gallus gallus (chicken); Xt: Xenopus 
tropicalis (frog); Dr: Danio rerio (zebrafish) 
EVS Alleles: Presence of amino acid per Exome Variant Server database 
SIFT: Sorting Intolerant From Tolerant (http://sift.bii.a-star.edu.sg ); D – deleterious 
MutationTaster (http://www.mutationtaster.org): DC – disease-causing 
PolyPhen-2 prediction score ranges from 0 (= benign) to 1 (= damaging), the closer to 1, 
the more damaging: 
 (http://genetics.bwh.harvard.edu/pph2/) 
 





CHAPTER 2 Hypothesis and Specific Aim 
2.1 Hypothesis 
 
The p.G114W mutation is located in the first Ig domain of ROBO2 in its 
extracellular region. As stated before, the first Ig domain is also the main binding site for 
the ligand SLIT2. ROBO2 binding of SLIT2 is necessary to initiate the chemorepulsion 
activity in neuronal migration (Pope et al., 1999). Previously, the Lu lab has shown that a 
truncated, tagged, wild type ROBO2 fusion protein containing the first Ig domain can act 
as a dominant-negative molecule, binding to the soluble SLIT2 ligand and preventing its 
interaction with wild type ROBO2 (Lu et al., 2007). This led to abnormal ROBO2/SLIT2 
activity in an in vitro neuronal migration assay preventing chemorepulsive activity of 
neuron migration from explants of the SVZa isolated from newborn rat brain (Lu et al., 
2007). Therefore, we hypothesize that by introducing the p.G114W mutation into the 
first Ig domain of the ROBO2 fusion protein (Figure 2), it will prevent the binding of the 
SLIT2 ligand to the mutant ROBO2 fusion protein with the p.G114W mutation and allow 
for SLIT2 to interact with wild type ROBO2 receptor on the neuron surface to prevent 








2.2 Specific Aim 
 
Aim: Determine if the p.G114W mutation in the ROBO2 fusion protein with the 1st Ig 
domain would abolish its binding to SLIT2 and lose its function to block SLIT2-
medicated inhibition of SVZa neuronal migration. 
  
We expect our studies to show: 
Aim expectations: The mutant ROBO2 fusion protein with the p.G114W mutation 
should act as a loss-of-function molecule with less of an effect on inhibiting the binding 
between recombinant SLIT2 and endogenous ROBO2 receptor expressed on the neurons 
in the SVZa explants as compared to the wild type ROBO2 fusion protein without the 
p.G114W mutation. We expect to see a less number of neuronal cells migrating outward 
from the SVZa explants treated with mutant ROBO2 fusion protein with the p.G114W 


















Figure 2: ROBO2 protein structure and location of missense mutation p.G114W in 
the ROBO2 fusion construct. A. ROBO2 protein structure with the 1st Ig domain (the 
SLIT2 binding site) indicated with the black arrow. Ig domains are labeled in Green, 
fibronectin three (FNIII) motifs in blue, and conserved cytoplasmic regions CC0, CC1, 
CC2, and CC3 in indigo; TM, Transmembrane domain. B. Wild type ROBO2 fusion 
protein construct is shown, which contains the 129 amino acids encoding the first Ig 
domain. Partial sequence around wild type Glycine (G, marked in red) at the 114th amino 
acid position is shown. C. Mutant ROBO2 fusion protein construct with p.G114W 





CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Q-5 Site Directed Mutagenesis 
 
ROBO2-WT-YFP constructs tagged with YFP (Venus) and HA (Previously 
developed as Fu129-HA and Fu129-Venus in Lu lab, truncated, 129 amino acid, ROBO2 
HA-Tagged and YFP(Venus) tagged, Fusion Protein constructs) were kindly obtained 
from the Lu lab (Lu et al., 2007).  New England Biolab (NEB) Q5 Site Directed 
Mutagenesis kit (New England Biolabs, Cat# E09.0554S) was used to introduce ROBO2 
point mutation of interest c.340G>T in the ROBO2 fusion constructs. NEBasechanger™ 
design software was used to develop forward and reverse primers (Appendix 1). 
Polymerase Chain Reactions (PCR) were prepared per NEB protocol as follows: 12.50 
microliters (µL) Q-5 Hot Start High Fidelity 2x Master Mix, 1.25 µL of 10 micromolar 
(µM) of forward primer, 1.25 µL of 10 µM reverse primer, 1.00 µL of ROBO2 fusion 
construct cDNA, and 9.00 µL of DNase/RNase-free deionized distilled water (ddH2O). 
The total PCR reactions volume is 25 µL.  
PCR reactions were performed in the Applied Biosystems Veriti 96 Well Fast 
Thermocycler (Thermo Fisher Scientific) according to following condition: initial 
denaturation at 98 degrees Celsius (°C) for 30 seconds, 25 cycles at 98°C for 10 seconds 
 67°C for 20 seconds  72°C for 200 seconds, final extension at 72°C for 120 
seconds.  
To generate the new ROBO2 fusion cDNA with the c.340G>T mutation, the PCR 
product was treated with the kinase, ligase, and DpnI (KLD) enzyme mix according to 
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the Q5 Site Directed Mutagenesis kit protocol before transfected into chemically 
competent Escherichia coli (E. coli) (NEB 5-alpha Competent E. coli (High Efficiency), 
NEB #C2987) to sub clone the ROBO2 fusion constructs with the c.340G>T following 
the standard molecular cloning protocol.  
 
3.2 Miniprep and Midiprep of ROBO2 fusion construct cDNA 
 
Isolations of ROBO2 fusion construct cDNA from E. coli cells were completed 
using QIAprep Spin Miniprep kit (Qiagen Cat No: 27104) and Qiagen plasmid Midi Kit 
(Qiagen Cat No: 12143) according to the manufacture protocol.  
 After isolation, cDNA samples were quantified using nanodrop (Thermo Fisher 
Scientific, Hanover Park, IL). 
 
3.3 Sanger Sequencing 
 
ROBO2 fusion construct DNA samples were sent in to Genewiz 
(https://www.genewiz.com/en) for Sanger Sequencing to verify for presence of a 
successful point mutation of c.340G>T. Standard universal primers T7 (Forward) and 
BGHR (Reverse) (Appendix 1) provided by Genewiz were used for sequencing. DNA 







3.4 Expression of ROBO2 fusion proteins in HEK cells and collection of conditioned 
media with secreted ROBO2 fusion proteins. 
 
To express ROBO2 fusion proteins, human embryonic kidney (HEK) 293T cells 
(American Type Culture Collection) were transfected with purified ROBO2 fusion cDNA 
using Calcium Phosphate transfection method. Briefly, HEK cells were cultured to ~80% 
confluent. The transfection mix was prepared consisted of ~20  µg/µL of ROBO2 fusion 
construct cDNA, 50 µL of calcium chloride (CaCl2), and ~ 400 µL of ddH2O, 500 µL of 
2x borate buffered saline (BBS) solution, 2 mL of DMEM. 1 mL of transfection mix was 
then added throughout the HEK cell culture. Transfected HEK cells were then placed in 
an incubator overnight at 37°C and 5% CO2. 
The efficiency of transfected HEK cells with YFP-tagged ROBO2 constructs 
were examined under Ultraviolet (UV) light for GFP/YFP signals. Since ROBO2 fusion 
constructs contain a signal peptide sequence that will produce secreted proteins, the 
conditioned medium with secreted ROBO2 wild type and mutant fusion proteins were 
collected after 24 hours culture and labeled accordingly. 
The transfected HEK cells were then scraped off the culture plate and were 
centrifuged at 13,000 revolutions per minute (RPM) for 15 seconds at room temperature. 
Cell pellets were lysed with 1 mL of prechilled 1x PBS/0.5%, Triton x100 (Tx100), and 
10 µL of 100x protease inhibitor. Cell lysates were centrifuged for 10 minutes in 4°C. 
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Supernatant was transferred to newly labeled Eppendorf tubes for downstream western 
blot analysis. 
 
3.5 Western Blot Assay 
 
 Western Blot Assay was completed according to published protocol in our lab (Lu 
et al., 2007). Briefly, HEK cells transfected with ROBO2 fusion constructs and YFP 
(Venus) pCS2 empty vector were collected. Conditioned media were collected 48 hours 
after transfection and centrifuged for 20 min at 4°C to remove cell debris. HEK Cells 
were lysed with 1x PBS, 0.5% Triton X-100, and 1x protease inhibitor. Cell lysates and 
conditioned media were then diluted with six-fold protein loading buffer, and heated at 
95°C for 20 min, resolved by 12% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). After electrophoresis run, proteins 
were transferred from gels onto nitrocellulose membranes (Thermo Fisher Scientific, 
IB23001 or IB23002). Membranes were incubated for blocking with 5% milk, washing 
with 1x TBS, and detected by monoclonal anti–GFP/YFP antibody. LICOR Odyssey 
CLx system was used to image protein bands. 
 
3.6 Neuronal Migration Assay 
 
 SVZa Neuronal Migration Assay was completed with the aid of Dr. Xueping Fan 
of the Lu laboratory at the Boston University according to previous published protocol 
(Lu et al, 2007; Hwang et al., 2015, p. 2). Briefly, SVZa cell explants were dissected 
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from 1-5 days old Sprague-Dawley rat brain. SVZa cell explants were cultured in plates 
coated with mixed gel complex containing collagen:matrigel:DMEM in a 3:2:1 ratio. 
SVZa cell explants were then co-incubated with (1) 100% DMEM alone (negative 
control), (2) 100% DMEM supplement with 1 nM recombinant SLIT2N (positive 
control), (3) culture media with conditioned medium:DMEM ratio at 25%/75%, (4) 
culture media with conditioned medium:DMEM ratio at 50%/50%, and (5) 100% 
conditioned medium without DMEM. Both conditioned media containing ROBO2 wild 
type and mutant fusion proteins were used. After 24 hours culture, images of SVZa 
explants and migrating cells were taken under 10x differential interference contrast (DIC) 
microscope. Cell numbers were calculated by dividing images into four quadrants, 
manually counting the top right quadrant, and multiplying by four. 
 
3.7 Statistical Analysis 
 
Statistical analysis was completed via unpaired student T-Test on Microsoft Excel 













CHAPTER 4: RESULTS 
4.1 Introduce c.340G>T mutation in ROBO2 fusion constructs using site directed 
mutagenesis.  
 
Our lab has previously generated HA and YFP (Venus) tagged wild type ROBO2 
fusion cDNA constructs that encode 129 amino acids covering the entire first Ig domain 
of the ROBO2 protein (Lu et al., 2007). With a signal peptide, this wild type ROBO2 
fusion protein (previously named as Fu-129) is secreted in cell culture medium and has 
been shown to act as a dominant-negative molecule to bind the soluble SLIT2 and 
prevent its interaction with ROBO2 leading to inhibition of its chemorepulsion activity in 
SVZa neuronal migration assay (Lu et al., 2007). Using site directed mutagenesis, we 
introduced the c.340G>T mutation in the wild type ROBO2 fusion cDNA to exchange 
the guanine for thymine at position 340 of the ROBO2 gene (reference sequence: 
NM_001128929.2). The mutant ROBO2 fusion construct with the c.340G>T mutation 
was verified by Sanger sequencing, which encoded the p.G114W mutation in the first Ig 


















Figure 3: Site-directed mutagenesis results of ROBO2 c.340G>T mutation in  
ROBO2 fusion constructs. A. Chromatogram from Sanger seqeucning shows a guanine 
(G, black arrow) in wild type ROBO2 cDNA that encodes the wild type ROBO2 fusion 
protein construct with partial amino acid (AA) sequence labeled accordingly. B. 
Chromatogram results showing mutation of a T (thymine) in ROBO2 mutant cDNA 
construct resulting in a glycine (G) to tryptophan (W) amino acid substitution. cDNA 
sequence labeled accordingly (G = guanine, C =  cytosine, A = adenine, T = Thymine) 
and amino acid (AA) sequence labeled accordingly (H = histidine, G = glycine, R = 






















4.2 Expression of ROBO2 wild type and mutant fusion proteins with p.G114W 
mutation   
 
To generate secreted wild type ROBO2 fusion protein and mutant ROBO2 fusion 
protein with the p.G114W mutation, we transfected HEK 293T cells with wild type and 
mutant ROBO2 fusion cDNA through calcium phosphate coprecipitation. The 
transfection efficiency was very high and was verified by green fluorescence signals of 
tagged YFP (Venus) in transfected cells compared to non-transfected cells (Figure 4, A-
C).   
 To determine if transfected HEK cells produced wild type and mutant ROBO2 
fusion proteins, we performed Western blot analysis to examine the YFP-tagged fusion 
protein in cell lysates and cell culture medium (Figure 4D).  Consistent with our previous 
report  (Lu et al., 2007), we observed protein bands of ~40 kDa in both cell lysates and 
cell culture medium (Figure 4D), confirming both wild type (ROBO2-WT-YFP) and 
mutant (ROBO2-MU-YFP) fusion proteins were generated and secreted in the cell 
culture medium (i.e. conditioned medium). Additionally, a band of 26 kDa was visible 
for control “YFP only” cell lysate but not for the control conditioned medium since there 



















Figure 4: Transfection and Western blot analysis of ROBO2 wild type and 
mutant fusion proteins with p.G114W mutation. A. HEK cells were transfected 
with YFP (Venus)-tagged ROBO2 fusion construct and viewed under UV-light 
showing green fluorescence with  >90% transfection efficiency. B. Non-transfected 
HEK cells viewed under UV-light show no green fluorescence signal. C. Non-
transfected HEK cells viewed under 10x DIC microscope showing healthy cell 
morphology. D. Western blot results show YFP-tagged ROBO2 wild type (ROBO2-WT-
YFP) and ROBO2 mutant with p.G114W mutation (ROBO2-MU-YFP) fusion proteins 
(~40 kDa) and YFP only empty vector (~26 kDa) detected by an anti-YFP antibody in 
HEK cell lysates.  ROBO2-WT-YFP and ROBO2-MU-YFP fusion proteins were also 
secreted into the medium (i.e. conditioned medium), but not for the YFP only empty 







4.3 ROBO2 Fusion Protein with p.G114W mutation loses its function to block 
SLIT2-mediated inhibition of neuronal migration in SVZa explants 
 
As mentioned before, predictive bioinformatics software has suggested a 
p.G114W mutation in ROBO2 is very likely to be damaging and disease-causing (Hwang 
et al., 2014). Our previous study has shown that wild type ROBO2 fusion protein without 
the p.G114W mutation in its first Ig domain can act as a dominant-negative molecule to 
bind SLIT2 and block SLIT2-medicated inhibition on neuronal cell migration from SVZa 
explants (Lu et al, 2007 AJHG). To determine if the ROBO2 mutant fusion protein with 
the p.G114W mutation could affect its binding capacity to SLIT2 and change SLIT2-
medicated chemorepulsive activity, we performed SVZa cell migration assays using the 
culture medium containing different concentrations of wild type and mutant ROBO2 
fusion proteins (Figure 5). First, we tested a negative (mock) SVZa cell migration 
condition with regular DMEM culture medium without adding any recombinant SLIT2 in 
the culture (Figure 5A). After 24-hour culture, neuronal cells showed maximum radial 
migration pattern from the center SVZa explants (Figure 5A). We then added 
recombinant SLIT2 in the culture medium and found that neuronal cell migration was 
completely blocked at 1 nM SLIT2 concentration (Figure 2B), confirming the positive 
chemorepulsive effect of SLIT2 on SVZa neurons (positive control).   
After established the negative and positive culture conditions for SVZa neuron 
migration, we tested the effect of wild type ROBO2 fusion protein conditioned medium 
obtained from transfected HEK cells at different concentrations. As we increased 
percentage of conditioned medium co-incubation in the culture from 25% to 50%, we 
 
26 
observed more cells migrated from the center of SVZa explants (Figure 5C, 5E), 
suggesting increased blocking of SLIT2-mediated inhibition of neuronal migration. As 
percentage of conditioned medium (CM) of wild type ROBO2 fusion protein increased 
further from 50% to 100%, significant more cells migrated from the center of SVZa 
explants although the SLIT2 concentration is not changed (Figure 5G).These results are 
consistent with previous findings showing that truncated ROBO2 fusion protein with the 
first Ig domain acts as a dominant-negative abrogating SLIT-ROBO signaling in vitro 
(Lu et al., 2007), where presence of the ROBO2 wild type fusion protein lead to 
increased migration of SVZa cells after 24 hours culture.   
We then tested the conditioned medium containing the mutant ROBO2 fusion 
protein with the p.G114W mutation. In comparison to the wild type ROBO2 fusion 
protein, increasing of concentration of the mutant p.G114W ROBO2 fusion protein 
conditioned medium did not increase the numbers of migrating cells from SVZa explants 
at both 50% and 100% conditioned medium concentration (Figure 5D, 5F, 5H). When we 
counted the number of migrating cells from the SVZa explants, we found that significant 
less of migrating cells were found in plates treated with 50% and 100%  conditioned 
medium containing the ROBO2 mutant fusion protein with the p.G114W mutation as 
compared to conditioned medium with the wild type ROBO2 fusion protein (Figure 5I). 
These data suggest that ROBO2 fusion protein with the p.G114W mutation lost its 







Figure 5: ROBO2 mutant fusion protein with p.G114W mutation lost its function to 
block SLIT2-mediated inhibition of neuronal migration in SVZa explants compared 
to wild type control. SLIT2-mediated inhibitions of neuronal migration from SVZa 
explants were shown. Tissue explants isolated from rat brain anterior subventricular zone 
A (SVZa) were embedded on plates coated with collagen and matrigel, and were cultured 
in DMEM with following condition: (A) 100% DMEM media alone with no SLIT2, 
Mock (negative control). (B) 1 nM SLIT2 only (positive control). (C) 1 nM SLIT2 plus 
25% conditioned medium (CM) containing wild type (WT) ROBO2 fusion protein. (D) 1 
nM SLIT2 plus 25% conditioned medium (CM) containing mutant (Mut) ROBO2 fusion 
protein. (E) 1 nM SLIT2 plus 50% conditioned medium (CM) containing wild type (WT) 
ROBO2 fusion protein. (F) 1 nM SLIT2 plus 50% conditioned medium (CM) containing 
mutant (Mut) ROBO2 fusion protein. (G) 1 nM SLIT2 plus 100% conditioned medium 
(CM) containing wild type (WT) ROBO2 fusion protein. (H) 1 nM SLIT2 plus 100% 
conditioned medium (CM) containing mutant (Mut) ROBO2 fusion protein. The area of 
migrating neuron cells from SVZa explants are marked by white dot lines. (I) 
Quantification of migrating neuron cell number from SVZa explants in panels A-H by 
counting individual cell nuclei outside the edge of the SVZa tissue explants. Data are 



























Chapter 5: DISCUSSION 
 
5.1 Discussion and Conclusion  
 
The ROBO2 p.G114W missense mutation reported by Hwang et. al. (Hwang et 
al., 2014) (also see Table 1) was initially predicted to be damaging and disease-causing 
by multiple bioinformatics prediction software (e.g. MutationTaster, SIFT, and PP-2). 
However, no in vitro functional mutation studies had been performed in the past. In this 
study, we successfully introduce this missense mutation into a ROBO2 fusion protein 
containing the first Ig domain that is the binding site for SLIT2 (Lu et al., 2007). We have 
also successfully expressed ROBO2 fusion proteins in HEK cells and produced 
conditioned medium that contain the secreted ROBO2 fusion proteins. With a sensitive 
SLIT2/ROBO2 signaling specific SVZa neuronal cell migration assay, we were able to 
demonstrate that the p.G114W mutation causes ROBO2 first Ig domain losing its 
inhibitory effect on SLIT2-medicated chemorepulsive activity. Our results provide 
evidence for the first time that p.G114W is a functional mutation, which may affect the 
binding capacity of ROBO2 to its ligand SLIT2 during early kidney development and 
contribute to the CAKUT phenotype in the patients carrying this p.G114W mutation.  
The mechanism of ROBO2 p.G114W mutation in the disruption of SLIT2 binding 
is less clear. We speculate that the disruption in binding of mutant ROBO2 first Ig 
domain and SLIT2 may be attributed to the size difference between glycine (G) and 
tryptophan (W) at the 114th amino acid position. With glycine being a much smaller 
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amino acid (molar mass 75.1 grams/mol) in comparison to tryptophan (molar mass 204.2 
grams/mol), this difference in size may cause a structural change of the ROBO2 first Ig 
domain leading to a decrease in the ability of ROBO2 to bind SLIT2. 
 
5.2 Limitations and Future Directions 
 
 There were a number of limitations to our study. First, due to the constraint of the 
time that was given for completion of this thesis, we were unable to demonstrate the 
direct disruption of the binding between mutant ROBO2 with the p.G114W mutation and 
SLIT2.  We initially intended to complete an overlay assay to determine the physical 
binding of SLIT2 to the mutant ROBO2 fusion protein and compare it to the binding of 
SLIT2 to the wild type ROBO2 fusion protein. The overlay assay was unsuccessful in a 
number of attempts.  
 Another limitation of our study was the inability to trace the presence of the HA 
tagged fusion proteins using western blot analysis in comparison to the YFP (Venus) 
tagged fusion proteins. This may have been due to the small protein size of HA tagged 
fusion proteins (~14 kDa) and the YFP (Venus) tagged fusion protein was much larger 
(~40 kDa) and therefore much easier to detect using western blot analysis.  
The largest constraint of this research thesis project was the time allotted for 
completion of experiments. Given the period allowed for the completion of this thesis, 
there was not a lot of time for trouble shooting and optimization of experiments to obtain 
necessary data. If more time was given, it would be optimal to be able to run the SVZa 
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assay using both the YFP (Venus) tagged fusion proteins and HA tagged fusion proteins. 
In addition, kinetic studies of protein-protein interaction using label-free detection 
methods such as Bio-Layer Interferometry (BLI) or Surface Plasmon Resonance (SPR) 
may give us to more quantitative data by determining equilibrium dissociation constants 
(KD) of wild type ROBO2 fusion protein and mutant ROBO2 fusion protein to SLIT2 
molecule. These data may help us to determine the effect of the p.G114W mutation on 
the binding affinity of SLIT2 for the ROBO2 first Ig domain.   
With the in vitro data generated in this thesis, it may give us the rationale to study 
the in vivo effects of this ROBO2 p.G114W mutation in animal models in the future by 
knock-in of the p.G114W mutation into the mouse Robo2 locus through the use of new 
genetic technology such as Clustered Regularly Interspaced Short Palindromic Repeats 
(CRISPR) - Cas9 genome editing. The development of this technology has greatly 
simplified the process of generating in vivo knock-in constructs with point mutations in 
animal models (Singh, Schimenti, & Bolcun-Filas, 2015). 
Additionally, the study of other ROBO2 missense mutations with similar 
damaging scores across the board from bioinformatics prediction software may also be 
beneficial to ascertain the effects of other missense mutations that have been discovered 
in families exhibiting the CAKUT phenotype. With the high costs of pediatric 
hospitalizations being due to genetic and congenital anomalies, and childhood renal tract 
anomalies being a big risk factor of kidney failure in adults, studying the genetic causes 
of congenital defects of the kidney and urinary tract may help us to develop new 
diagnostic tools, generate new knowledge of disease mechanisms, and discovery novel 
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treatment for patients with CAKUT and other kidney diseases (Calderon-Margalit et al., 










































Appendix 1: Forward and Reverse Primers 
 ROBO2-Mu-YFP Mutant (NEBasechanger™) 
 Oligo Length(nt) %GC Tm Ta 
Forward 5’-CATCGTGCACtGGCGCAGGAG-3’ 21 67 69°C 67°C 
Reverse 5’-CGCAAGAAGAATAAGGATCCGC-3’ 22 50 66°C 67°C 
  
 Standard Sequencing Universal Primers (Genewiz) 
 Oligo Length(nt) %GC Tm Ta 
T7 5’-TAATACGACTCACTATAGGG-3’ 20    
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